osimertinib
astrazeneca
[]
 at the end, the true cure rate - ie dfs curves never merging - will tell us whether it s worth the investment - just like with adj chemo. but we don t know yet. though the fact that neo-adj osi yielded 0% pcr rate makes me doubt its ability to eradicate micromets in adj setting